Vanderbilt University researcher William Mitchell, M.D., Ph.D., and colleagues in Germany and Canada have demonstrated a method for detecting “cell-free” tumor DNA in the bloodstream.
News: Urologic CancersNext Page »
Findings suggest a combination of therapies that may be effective in treating resistant prostate cancers
David Penson, M.D., will become chair of Vanderbilt’s Department of Urologic Surgery, effective Jan. 1, 2015.
Two urologic surgeons at Vanderbilt-Ingram Cancer Center are among a leading group of cancer physicians using an innovative new imaging agent and blue light system to “light up” cancerous cells inside the bladder. The combined system is used to confirm non-invasive papillary cancer inside the bladder and help surgeons detect and remove more of the […]
Nearly 15,000 people in the United States die each year from metastatic bladder cancer. Signaling pathways that cause bladder tumor recurrence and spread are not clear. David DeGraff, Ph.D., a post-doctoral fellow in Urologic Surgery, and a multi-disciplinary team of colleagues including basic scientists, clinical pathologists and urologic surgeons, examined the role of the transcription […]
Earn up to 5.5 continuing education credits! Program Overview: This congress is a full-day educational program designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Bladder, Kidney, and Prostate Cancers. Participants will learn how to implement the NCCN Guidelines recommendations into their […]
Vanderbilt-Ingram Cancer Center cordially invites you and your guests to join us for Going for the Gold: Living Well through Cancer! Due to an overwhelming response, we have closed registration. We are thrilled to have so many people attend! Date: Saturday, June 30, 2012 Time: 9:30 a.m.-2:30 p.m. Where: Vanderbilt University Student Life Center 310 […]
The Agency for Healthcare Research and Quality (AHRQ) of the U.S. Department of Health & Human Services recently appointed Vanderbilt’s David Penson, M.D., MPH, to the National Advisory Council for Healthcare Research and Quality. Penson, professor of Urologic Surgery and director of the Center for Surgical Quality and Outcomes, joins a 21-member panel comprised of […]
Join us on March 20 for a FREE informative evening on your health and wellness. Event is located at Vanderbilt-Ingram Cancer Center at Green Hills 3810 Bedford Avenue Suite 100 Nashville, TN 37215 6 p.m. Registration & Refreshments 6:30 p.m. Speaker 7:15 p.m. Questions & Answers Quitting tobacco is the best thing that you can […]
The size of a man’s prostate gland may help predict the severity of cancer, with a smaller prostate being more likely to harbor serious disease. This finding by a group of Vanderbilt-Ingram Cancer Center researchers was published in the December issue of the Journal of Urology. Fourth-year medical resident Judson Davies, M.D., was first author […]